Navigation Links
Dual Gene Therapy Suppresses Lung Cancer in Preclinical Test

small cell lung cancer by 70 to 80 percent 48 hours after treatment while leaving a control group of normal cells unaffected. The cancer cell lines treated with the gene combination had 2 to 3 times more cells killed by apoptosis than either gene nanoparticle had individually. The research team then confirmed these findings in the mouse studies.

The nanoparticle delivery system, which the researchers have used for years, consists of a plasmid gene expression cassette loaded with DNA that encodes either the p53 or the FUS1 protein. This is wrapped tightly in a form of cholesterol to protect it from the body's defense mechanisms. 'You can't deliver naked DNA for cancer therapy,' Ji says.

The nanoparticles accumulate mainly in the lungs, particularly in the tumors, Ji says. The positively charged nanoparticles are delivered to the negatively charged cancer cell membrane and taken into the cell, where the genes repeatedly express either p53 or FUS1 tumor-suppressing proteins.

Roth expects the research team to advance combination therapies to clinical trials in the coming years, either of genes or of genes with other biologic or chemotherapy agents.

'We certainly hope this approach will be more effective but we also think it's likely to be much less toxic, with fewer side effects, than other types of combined cancer therapy,' Roth says. 'These genes don't have much effect on normal tissue or normal cells when they are overexpressed. It's really just cancer cells where they seem to have their effect. Ultimately, the usefulness of this approach has to be proven in clinical trials.'

Source-Newswise
'"/>




Page: 1 2

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dual Gene Therapy Suppresses Lung Cancer Preclinical Test

(Date:12/26/2014)... 2014 It is said that nothing makes ... UWDress.com, the famous wedding dress supplier, shows its new ... cocktail gown promotion. , UWDress.com’s navy cocktail gowns are ... come in high fashion styles. Simple dresses in bright neon ... occasion; they are specially designed for those who want to ...
(Date:12/26/2014)... WA (PRWEB) December 26, 2014 “Many ... deal with personal injury claim issues and phone calls ... recently released an article featuring their free eBook ... exceptionally helpful eBook on pedestrian and bicycle auto accident ... attorney is fully capable of professionally handling their case ...
(Date:12/25/2014)... December 26, 2014 The microscopy ... of 7.2% to reach $5,756.0 million by 2019. ... microscopy market. The electron microscopes product segment is ... forecast period. , Rising focus on nanotechnology, technological ... of the microscopy market. , Get Full Copy ...
(Date:12/25/2014)... 25, 2014 Product liability lawsuits filed ... recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in ... Order issued in the U.S. District Court, Northern District ... an open conference on January 7, 2015, at the ... in West Palm Beach, Florida. The Conference is scheduled ...
(Date:12/25/2014)... Recently, BellasDress has launched its Christmas Sale, ... has chosen their best-selling lace wedding dresses, vintage bridesmaid ... season. , Now, BellasDress.com features popular women’s dresses, ... discount prices. The business hopes everyone can have a ... , “All our elegant products are made with exquisite ...
Breaking Medicine News(10 mins):Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
... BLOOMINGTON, Ind. -- Indiana University researchers will use ... to examine the toll firefighting takes on firefighters, ... improve firefighter health and safety, and reduce the ... line of duty. , The U.S. Department ...
... With Jack Welch, January 29 - February ... LONDON, October 29 Jack Welch, Former Chairman ... Lean Six Sigma Healthcare Summit, providing,a unique opportunity ... improvement issues with the leading figure in Six ...
... CEL-SCI Corporation,(Amex: CVM ) announced today that it ... its new website. The link is located in,the top ... http://www.cel-sci.com . Geert Kersten, Chief Executive Officer ... the future of cancer therapy. We have,created an easy ...
... through ... Affordable Healthcare, HOUSTON, Oct. 29 As employer healthcare ... is good news on the,horizon. Recent research sponsored by the ... agency, shows retail,clinics can be particularly effective in improving employee ...
... teachers in a recent survey commissioned by The Innovation ... of Bristol. Although current teacher training programmes generally omit ... of the teachers surveyed felt neuroscience could make an ... was undertaken to inform a series of seminars between ...
... the developing world because of lack of investment in ... Highness The Duke of York, Patron of the Association ... In the foreword to a special supplement on anaesthesia ... of York says that this situation is in stark ...
Cached Medicine News:Health News:Fit to fight: $1 million grant to focus on firefighters' health 2Health News:Jack Welch to Headline the 8th Annual Lean Six Sigma Healthcare Summit 2Health News:Houston Employers Hear New Research That Supports the Case for Retail Clinics 2Health News:Houston Employers Hear New Research That Supports the Case for Retail Clinics 3Health News:Houston Employers Hear New Research That Supports the Case for Retail Clinics 4Health News:What's the brain got to do with education? 2Health News:British Royal highlights anesthesia crisis in the developing world 2
(Date:12/24/2014)...  The International Trade Commission (ITC) issued its final decision ... In a notice issued on December 23, the ITC ruled ... its humidifier was invalid. BMC President, James ... very excited with the ITC,s decision in this case. This ... since the very beginning on the key patents in the ...
(Date:12/24/2014)... SCHOFIELD, Wis. , Dec. 23, 2014 ... and marketer of over-the-counter (OTC) medicinal and healthcare products, ... production of MigraPure® H, a hemp-based, advanced headache relief ... marijuana dispensaries in Colorado , ... . With the MigraPure H Advanced ...
(Date:12/24/2014)... 2014   Synageva BioPharma Corp. (NASDAQ: ... therapeutic products for rare disorders, today announced validation ... Marketing Authorization Application (MAA) for sebelipase alfa for ... request for accelerated assessment, which has the potential ... The MAA, and the Biologics License ...
Breaking Medicine Technology:ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
... Jan. 4, 2011 Isis Pharmaceuticals, Inc. (Nasdaq: ... , Recent Advances in Isis, Development PipelineWhen: , ... / 9:00 a.m. PTWhere: , www.isispharm.comHow: , Live ... site listed above. Contacts: , Kristina LemonidisDirector, Investor ...
... 2011 PAREXEL International Corporation (Nasdaq: PRXL ) ... Healthcare Conference in San Francisco.  Josef von Rickenbach, Chairman and ... at 8:30 a.m. PT on Thursday, January 13, 2011. ... through the "Investors" section of PAREXEL,s website at ...
Cached Medicine Technology:PAREXEL International to Present at J.P. Morgan Healthcare Conference 2
... to 350 Liters of pure water, Complete, ... of Purified Water,Millipores compact S.D.S. Storage and ... to 350 liters of purified water produced ... maintain consistent purity of stored water, provide ...
... developed a range of Milli-Q ultrapure ... water quality requirements. Each of the ... to specifically target contaminants detrimental to ... biology and ICP-MS. The systems incorporate ...
... Millipore has developed a range ... to match specific water quality requirements. ... systems is designed to specifically target ... as HPLC, molecular biology and ICP-MS. ...
... a range of Milli-Q ultrapure water ... quality requirements. Each of the five ... specifically target contaminants detrimental to particular ... and ICP-MS. The systems incorporate a ...
Medicine Products: